Dörner, Thomas
Kay, Jonathan
Article History
First Online: 18 August 2015
Change Date: 25 August 2015
Change Type: Correction
Change Details: In the version of this article initially published online, the line colours in Figure 4 were incorrect. The error has been corrected for the print, HTML and PDF versions of the article.
Competing interests
: T.D. declares that he has received honoraria for study support and consultations from Hospira, Johnson & Johnson, Merck Sharp & Dohme, Pfizer, Roche/Chugai, Samsung, Sanofi and UCB. J.K. declares that he has received research support (paid to the University of Massachusetts Medical School) from AbbVie, Genentech, Pfizer and Roche Laboratories, and honoraria for consultations from Amgen, AbbVie, Boehringer Ingelheim, Bristol–Myers Squibb, Epirus Biopharmaceuticals, Genentech, Hospira, Janssen Biotech, Merck Sharp & Dohme, Nippon Kayaku, Novartis Pharmaceuticals, Pfizer, Samsung Bioepis, Roche Laboratories and UCB.